Denosumab Clinical Trials
11 recruitingDrug
Phase 45Phase 23Phase 12Not Applicable1
Showing 1–11 of 11 trials
Recruiting
Phase 1Phase 2
Zunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer With Bone Metastasis
Hormone Receptor Positive HER-2 Negative Metastatic Breast Cancer
Washington University School of Medicine152 enrolled3 locationsNCT06374459
Recruiting
Not Applicable
Study of the Key Techniques of Prevention and Treatment of Osteoporotic Refracture
Osteoporotic Fractures
Peking Union Medical College Hospital2,478 enrolled58 locationsNCT05866029
Recruiting
Phase 4
The Effect of Denosumab on Muscle and Strength and Insulin Sensitivity
Osteoporosis
Aarhus University Hospital40 enrolled1 locationNCT07271771
Recruiting
Phase 4
Romosozumab and Denosumab, Alone or Combined, in Postmenopausal Osteoporosis
Osteoporosis
National Taiwan University Hospital90 enrolled1 locationNCT07283887
Recruiting
Phase 1Phase 2
Denosumab for Type 1 Diabetes
Type 1 Diabetes
City of Hope Medical Center45 enrolled3 locationsNCT06524960
Recruiting
Sequential Therapies After Osteoanabolic Treatment
Osteoporosis, Postmenopausal
424 General Military Hospital150 enrolled8 locationsNCT06164795
Recruiting
Phase 4
Markers of Osteoporosis in Cystic Fibrosis
Cystic Fibrosis
University of Texas Southwestern Medical Center100 enrolled1 locationNCT03921060
Recruiting
Clinical Study of Desuzumab in the Treatment of Knee Osteoarthritis
Knee Osteoarthritis
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology30 enrolled1 locationNCT06357741
Recruiting
Phase 2
An Exploratory Study of Tislelizumab in Combination with Chemotherapy in Immuno-experienced Patients with EGFR/ALK/ROS1-negative Advanced NSCLC in the Second-line Setting
Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China22 enrolled1 locationNCT06749886
Recruiting
Phase 4
Romosozumab Versus Denosumab in GIOP: a 2-year Extension Study
OsteoporosisGlucocorticoids Toxicity
Tuen Mun Hospital63 enrolled1 locationNCT06472050
Recruiting
Phase 4
RANK-ligand Inhibition to Combat Sarcopenia with Underlying Osteoporosis
Sarcopenia in Elderly
Prince of Wales Hospital, Shatin, Hong Kong120 enrolled1 locationNCT06643780